Replies to post #22029 on American Bio Medica Corp (ABMC)

[The Rainbow]

Regulatory issues between the US and China were the major "supply issue" to overcome.

Healgen has been manufacturing and shipping on schedule since June.

Let's be clear that the difficulties receiving adequate numbers of test kits was a worldwide issue (past tense: WAS) that resolved itself in May and June.

Product availability was an issue for all distributors, manufactures, material suppliers and customers due to historical demand for test kits caused by the Corona Virus pandemic, along with governmental regulations that had to be worked out.

Governmental regulations were resolved
Manufacturing ramped up
Quality of the Healgen test kits was validated

[bk1287]

I have it from an e-mail on August 4th, so as of 8/4, they had no issues.

Me:
In your most recent filings, you expressed logistical issues with China and getting the tests. Have those since been resolved or are you still facing issues?

Melissa:
In the filing we did state that there were initially issues with supply due to specific regulatory events that occurred from March 2020 until May 2020. Our filing was just made last week. If the issues were continuing, we would have indicated that in the document.